Skip to content

Clinical study on Dabur gel in reduction of oral malodor.

Clinical study to evaluate the efficacy and safety of an oral care product on oral malodour reduction and its causative microflora in healthy adult subjects

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034750
Enrollment
60
Registered
2021-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R196- Halitosis

Interventions

Intervention1: Gel toothpaste: 2-3 gm for brushing twice a day for 30 days Control Intervention1: Marketed comparator: 2-3 gm for brushing twice a a day for 30 days

Sponsors

Dabur India limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: � Having at least 16 natural, permanent teeth. � Subjects with bad oral hygiene and halitosis (self-reported or clinically diagnose). Subjects who have plague and dental caries. � Subjects willing to give their swab samples for analysis. � Subjects willing to follow 12 hr. overnight gap of brushing/mouthwash and 4 hr. fasting after brushing on day 30 assessment. � Subjects willing to come for follow up visits at the specified time. � Subjects ready to follow instructions during the study period. � Subjects who use oral hygiene products other than Dabur. � Subject able to read, understand and sign an appropriate informed consent form indicating willingness to participate.

Exclusion criteria

Exclusion criteria: � A known history or present condition of hyper sensitivity to any toothpaste. � The use of antibiotic, antimicrobial, analgesic medications, mouthwash or desensitizing toothpaste during the previous 1 month. � Any history of periodontal therapy by surgical interventions. � Any history of dentine hypersensitivity treatment. Subjects having moderate to severe dentine hypersensitivity. � Orthodontic treatment with �xed appliances. � Any removable device such as a removable partial denture or orthodontic retainer. � The presence of any �xed appliance, large or defective restorations, cracked enamel, � History of smoking or use of smokeless tobacco products. � Subjects having moderate to severe dentine hypersensitivity. � Subjects having abnormal frenum attachment. � Subjects who are pregnant, lactating or nursing. � Subjects having severe level of calculus and/ tartar. � Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness.

Design outcomes

Primary

MeasureTime frame
� Significant reduction in malodour causing Bacteria by CFU log reduction at various time points in comparison to the baseline and with comparator. � Significant reduction in malodour by Oral Chroma assessment at various time points in comparison to the baseline and with comparator. � Significant reduction (X%) in oral microflora with product use and with comparator. Timepoint: Day 1-T0,Timm, Day30-T0, Timm, T4hr and T12hr

Secondary

MeasureTime frame
�Significant reduction in plaque, gingivitis, bleeding index and oral hygiene index with regular use of test product at various time points in comparison to the baseline and with comparator. Timepoint: Day1-T0,Timm, Day30-T0,Timm

Countries

India

Contacts

Public ContactMs Ritambhara

Dabur India Limited

sasibhushan.vedula@dabur.com01204378614

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026